Literature DB >> 35190946

Predicting counterfactual risks under hypothetical treatment strategies: an application to HIV.

Barbra A Dickerman1,2, Issa J Dahabreh3,4,5, Krystal V Cantos6, Roger W Logan3,4, Sara Lodi3,4,7, Christopher T Rentsch8,9,10, Amy C Justice9,10,11, Miguel A Hernán3,4,5,12.   

Abstract

The accuracy of a prediction algorithm depends on contextual factors that may vary across deployment settings. To address this inherent limitation of prediction, we propose an approach to counterfactual prediction based on the g-formula to predict risk across populations that differ in their distribution of treatment strategies. We apply this to predict 5-year risk of mortality among persons receiving care for HIV in the U.S. Veterans Health Administration under different hypothetical treatment strategies. First, we implement a conventional approach to develop a prediction algorithm in the observed data and show how the algorithm may fail when transported to new populations with different treatment strategies. Second, we generate counterfactual data under different treatment strategies and use it to assess the robustness of the original algorithm's performance to these differences and to develop counterfactual prediction algorithms. We discuss how estimating counterfactual risks under a particular treatment strategy is more challenging than conventional prediction as it requires the same data, methods, and unverifiable assumptions as causal inference. However, this may be required when the alternative assumption of constant treatment patterns across deployment settings is unlikely to hold and new data is not yet available to retrain the algorithm.
© 2022. Springer Nature B.V.

Entities:  

Keywords:  Causal inference; Counterfactual prediction; Dataset shift; Machine learning; Parametric g-formula; Transportability

Mesh:

Year:  2022        PMID: 35190946      PMCID: PMC9189026          DOI: 10.1007/s10654-022-00855-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   12.434


  21 in total

1.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

2.  Per-Protocol Analyses of Pragmatic Trials.

Authors:  Miguel A Hernán; James M Robins
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245

3.  Causal Inference Under Multiple Versions of Treatment.

Authors:  Tyler J VanderWeele; Miguel A Hernán
Journal:  J Causal Inference       Date:  2013-05-01

4.  Veterans Aging Cohort Study (VACS): Overview and description.

Authors:  Amy C Justice; Elizabeth Dombrowski; Joseph Conigliaro; Shawn L Fultz; Deborah Gibson; Tamra Madenwald; Joseph Goulet; Michael Simberkoff; Adeel A Butt; David Rimland; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Sheldon Brown; David A Leaf; Matthew B Goetz; Kendall Bryant
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

5.  Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals.

Authors:  Janet P Tate; Jonathan A C Sterne; Amy C Justice
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

6.  Extending inferences from a randomized trial to a new target population.

Authors:  Issa J Dahabreh; Sarah E Robertson; Jon A Steingrimsson; Elizabeth A Stuart; Miguel A Hernán
Journal:  Stat Med       Date:  2020-04-06       Impact factor: 2.373

7.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Authors:  Karel G M Moons; Douglas G Altman; Johannes B Reitsma; John P A Ioannidis; Petra Macaskill; Ewout W Steyerberg; Andrew J Vickers; David F Ransohoff; Gary S Collins
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

8.  Prediction meets causal inference: the role of treatment in clinical prediction models.

Authors:  Nan van Geloven; Sonja A Swanson; Chava L Ramspek; Kim Luijken; Merel van Diepen; Tim P Morris; Rolf H H Groenwold; Hans C van Houwelingen; Hein Putter; Saskia le Cessie
Journal:  Eur J Epidemiol       Date:  2020-05-22       Impact factor: 8.082

9.  Counterfactual prediction is not only for causal inference.

Authors:  Barbra A Dickerman; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2020-07       Impact factor: 8.082

10.  An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Authors:  Janet P Tate; Amy C Justice; Michael D Hughes; Fabrice Bonnet; Peter Reiss; Amanda Mocroft; Jacob Nattermann; Fiona C Lampe; Heiner C Bucher; Timothy R Sterling; Heidi M Crane; Mari M Kitahata; Margaret May; Jonathan A C Sterne
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.